267 related articles for article (PubMed ID: 8420607)
1. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.
Hsing AW; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1993; 2(1):27-32. PubMed ID: 8420607
[TBL] [Abstract][Full Text] [Related]
2. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
3. Early and late long-term effects of vasectomy on serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone levels.
Mo ZN; Huang X; Zhang SC; Yang JR
J Urol; 1995 Dec; 154(6):2065-9. PubMed ID: 7500459
[TBL] [Abstract][Full Text] [Related]
4. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
6. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic serum hormones and the risk of prostate cancer.
Nomura A; Heilbrun LK; Stemmermann GN; Judd HL
Cancer Res; 1988 Jun; 48(12):3515-7. PubMed ID: 3370644
[TBL] [Abstract][Full Text] [Related]
8. The endocrine profiles in men with localized and locally advanced prostate cancer treated with radical prostatectomy.
Heracek J; Urban M; Sachova J; Kuncova J; Eis V; Mandys V; Hampl R; Starka L
Neuro Endocrinol Lett; 2007 Feb; 28(1):45-51. PubMed ID: 17277727
[TBL] [Abstract][Full Text] [Related]
9. Control of prostate growth.
Coffey DS; Isaacs JT
Urology; 1981 Mar; 17(Suppl 3):17-24. PubMed ID: 6163242
[No Abstract] [Full Text] [Related]
10. High-grade prostate cancer is associated with low serum testosterone levels.
Schatzl G; Madersbacher S; Thurridl T; Waldmüller J; Kramer G; Haitel A; Marberger M
Prostate; 2001 Apr; 47(1):52-8. PubMed ID: 11304729
[TBL] [Abstract][Full Text] [Related]
11. Serum androgens: associations with prostate cancer risk and hair patterning.
Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF
J Androl; 1997; 18(5):495-500. PubMed ID: 9349747
[TBL] [Abstract][Full Text] [Related]
12. [Serum levels of gonadotrophins, testosterone and estradiol in acne vulgaris].
Krause W
Hautarzt; 1977 Jul; 28(7):368-70. PubMed ID: 142752
[TBL] [Abstract][Full Text] [Related]
13. Hormones and the pathophysiology of fibrocystic mastopathy: elevated luteinizing hormone levels.
Golinger RC; Krebs J; Fisher ER; Danowski TS
Surgery; 1978 Aug; 84(2):212-5. PubMed ID: 684613
[TBL] [Abstract][Full Text] [Related]
14. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
[TBL] [Abstract][Full Text] [Related]
15. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
[TBL] [Abstract][Full Text] [Related]
16. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
17. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
de Jong FH; Oishi K; Hayes RB; Bogdanowicz JF; Raatgever JW; van der Maas PJ; Yoshida O; Schroeder FH
Cancer Res; 1991 Jul; 51(13):3445-50. PubMed ID: 1711411
[TBL] [Abstract][Full Text] [Related]
18. [Hormone determinations in andrology].
Frick J
Andrologia; 1980; 12(3):211-8. PubMed ID: 6778255
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of hypothalamic-pituitary-testicular axis hormones in men with or without prostate cancer or atypical small acinar proliferation.
Schmitt Cda S; Rhoden EL; Almeida GL
Clinics (Sao Paulo); 2011; 66(2):183-7. PubMed ID: 21484031
[TBL] [Abstract][Full Text] [Related]
20. Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L
Anticancer Res; 2011 Nov; 31(11):3913-20. PubMed ID: 22110219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]